4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-016051
Chairman and CEO acquired 822 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2024-08-01 | Other acquisition 10b5-1 | +44 | $1.47 | $65 | 5,696,925 | D: show line 1 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-02 | Other acquisition 10b5-1 | +40 | $1.44 | $58 | 5,696,965 | D: show line 2 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-05 | Other acquisition 10b5-1 | +19 | $1.42 | $27 | 5,696,984 | D: show line 3 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-06 | Other acquisition 10b5-1 | +39 | $1.46 | $57 | 5,697,023 | D: show line 4 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-07 | Other acquisition 10b5-1 | +44 | $1.50 | $66 | 5,697,067 | D: show line 5 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-08 | Other acquisition 10b5-1 | +28 | $1.45 | $41 | 5,697,095 | D: show line 6 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-12 | Other acquisition 10b5-1 | +25 | $1.43 | $36 | 5,697,120 | D: show line 7 in the form |
| KAZIMI A J Chairman and CEO | 2024-08-13 | Other acquisition 10b5-1 | +70 | $1.43 | $100 | 5,697,190 | D: show line 8 in the form |
Loading xslF345X05/marketforms-66911.xml…